Johnson & Johnson announced a significant milestone with its TECNIS ODYSSEY IOL being implanted in 100,000 eyes in the U.S. since its 2024 launch. As the fastest-growing presbyopia-correcting intraocular lens (PC-IOL) in the country, it was a focal point of the company’s showcase at the 2025 AAO Annual Meeting from October 18–20.
The TECNIS ODYSSEY IOL distinguishes itself through high-performance features, including 95% light utilisation and superior image contrast that outperforms leading monofocal lenses in low-light conditions.
Key Opinion Leader Dr Low Jin Rong (Ophthalmologist at Cornerstone Eye Centre (Novena), a member of Asian Healthcare Specialist), answers top FAQs about cataract surgery and IOLs on Health365.
Johnson & Johnson Press Release
OCTOBER 13, 2025 – Johnson & Johnson, a global leader in eye health, is pleased to announce that the TECNIS ODYSSEY IOL, the fastest-growing PC-IOL in the U.S.,^ has been implanted in 100,000 eyes* in the U.S. since launch in 2024. Johnson & Johnson will present the TECNIS ODYSSEY IOL, innovative advancements in laser cataract surgery and phacoemulsification, and fresh insights from investigator-initiated studies at the 2025 AAO Annual Meeting, October 18-20. The new clinical data will be presented validating surgical outcomes and patient satisfaction across the full cataract and refractive surgery portfolio—reinforcing confidence in procedural efficacy and patient-centered care.
INNOVATION
TECNIS ODYSSEY IOL delivers over 95% of light utilization,1 supporting image quality2,3,4 and visual acuity, giving patients sharp, clear vision with minimal distortion in real-world settings.5,6 Additionally, TECNIS ODYSSEY IOL delivers superior image contrast day and night, outperforming the leading competitor monofocal IOL in low-light conditions.2,3,7≠ Together, these attributes position TECNIS ODYSSEY IOL as a PC-IOL of choice for surgeons seeking to give patients uncompromising quality across the full visual range. TECNIS ODYSSEY IOL also provides:
· Enhanced tolerance to refractive error8 €
· Optimized dysphotopsia profile9 €
· Unmatched range of vision 10 ** ¶
SURGICAL EQUIPMENT PORTFOLIO
Historically, as of 2023, CATALYS Precision Laser System has carried the #1 LCS utilization rate in the industry.11 CATALYS System cOS 7.0 will be showcased at the conference, which includes integration with a biometer to enable seamless pre-operative measurements and astigmatism management capabilities. Surgeons who’ve used the cOS 7.0 reported 100% confidence in their ability to treat more patients with ease and precision. The upgrade is currently available in the US.12
VERITAS Vision System’s Hybrid Fluidics Technology delivers exceptional chamber stability through the combination of an Advanced Tubing System (ATS), Dual Pump, and Advanced Infusion.13,14,15,16,17
Surgeons on site will gain firsthand insights into the equipment’s superior control, advanced capabilities, and ease of use through a wet lab experience.
DATA
Investigator-initiated data shows positive outcomes and satisfaction rates across the Johnson & Johnson ophthalmic portfolio.
· Optical Phenomena and Tolerance to Simulated Astigmatism of a Violet light filtering Diffractive Full-Range Vision Intraocular Lens; 30082042; Karolinne Rocha, MD, et. Al.
o A study evaluating the tolerance to induced astigmatism and visual symptoms in eyes implanted with a diffractive full-range of vision (FVR) IOL with a violet-light filter (TECNIS ODYSSEY IOL) found:
§ The new FVR IOL (TECNIS ODYSSEY IOL) exhibited satisfactory tolerance to induced astigmatism.
· Clinical and Patient-Reported Outcomes of Mild Glaucoma Patients Implanted with Extended Depth of Focus IOLs; 30083549; Zarmeena Vendal, MD.
o A study evaluating clinical and patient-reported outcomes following bilateral implantation of TECNIS Symfony OptiBlue in patients diagnosed as glaucoma suspects or with mild glaucoma found:
- All subjects were 20/30 or better at all distances,
- Spectacle independent at all distance and intermediate,
- Suggesting violet-light filtering EDOF IOLs can provide glaucoma patients with the opportunity to enjoy good vision at all distances.
Johnson & Johnson can be found at booth #2509.
See Johnson & Johnson‘s full Press Release.
